Analyst consensus rating
Addus HomeCare Analyst Rating: Buy
ADUS is rated Buy by 13 analysts with a $134.69 target. As of 2026-08-24.
Direct answer
Addus HomeCare's consensus rating is Buy.
13 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $134.69.
Forecast evidence checked August 24, 2026.
Get free Addus HomeCare email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $120.85
- Average price target
- $134.69
- High price target
- $155.00
- Low price target
- $96.00
- Low target gap
- -20.6%
- Target upside
- +11.5%
- High target gap
- +28.3%
- Target range width
- 48.8%
- Consensus rating
- Buy
- Analysts
- 13
- Evidence date
- August 24, 2026
- Valid through
- August 31, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Addus HomeCare?
Addus HomeCare has a verified Buy consensus. The same dataset has an average price target of $134.69.
How far are Addus HomeCare's low and high targets from the recorded price?
The low target implies -20.6%, while the high target implies +28.3%.
How many analysts are included in Addus HomeCare's consensus?
The verified consensus includes 13 analysts.
How is Addus HomeCare's target upside or downside calculated?
The average target of $134.69 is divided by the recorded price of $120.85, then one is subtracted to produce +11.5%. This does not guarantee a future return.
When was Addus HomeCare's analyst forecast verified?
The data was verified on 2026-08-24. The dataset is valid through 2026-08-31.